Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hydreight Technologies Inc ( (TSE:NURS) ) has provided an announcement.
At its 2025 Annual General Meeting, Hydreight Technologies Inc. announced that all proposed items of business were approved by shareholders, including the election of director nominees and the fixed omnibus equity incentive plan. The plan allows for the issuance of up to 9,000,000 common shares through various equity-based awards, pending final approval from the TSX Venture Exchange. The reappointment of key executives, including CEO Shane Madden, underscores the company’s strategic continuity.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates in the technology sector, focusing on providing innovative solutions. The company is involved in the development and implementation of equity-based incentive plans and has a presence on multiple stock exchanges, including TSXV, OTC, and FSE.
Average Trading Volume: 350,483
Technical Sentiment Signal: Buy
Current Market Cap: C$115.8M
See more insights into NURS stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges
- Elon Musk’s 2018 Stock Shares Go Live, Tesla Stock (NASDAQ:TSLA) Slips